Hundreds of health care artificial intelligence (AI) tools have been cleared by the U.S. Food and Drug Administration (FDA), yet only a fraction are rigorously evaluated for clinical impact, fairness or bias. Furthermore, the FDA review only covers a small portion of health AI tools being developed and used in health care. The American Heart Association (Association), a global force changing the future of health for all, today released a new science advisory urging health systems to adopt clear and simple rules for using AI in patient care.
New guidance offered for responsible AI use in health care
